Advertisement
Screener

P3 Health Partners Inc. (PIII) Business Acquisition, Pro Forma Net Income (Loss)

P3 Health Partners Inc. Business Acquisition, Pro Forma Net Income (Loss)

P3 Health Partners Inc. (PIII) reported Business Acquisition, Pro Forma Net Income (Loss) of -$45.12 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.

Discontinued › Expense Statement › Operating Expenses

us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2023-03-31

  • P3 Health Partners Inc. business acquisition, pro forma net income (loss) for the quarter ending 2021-12-31 was -$13.88M.
  • P3 Health Partners Inc. business acquisition, pro forma net income (loss) for the quarter ending 2021-09-30 was -$991.13K.
  • P3 Health Partners Inc. business acquisition, pro forma net income (loss) for the quarter ending 2021-06-30 was -$17.69M.
  • P3 Health Partners Inc. business acquisition, pro forma net income (loss) for the quarter ending 2021-03-31 was -$12.55M.
  • P3 Health Partners Inc. business acquisition, pro forma net income (loss) for fiscal 2021 was -$45.12M.
  • P3 Health Partners Inc. business acquisition, pro forma net income (loss) for fiscal 2020 was -$34.61M.
Period endBusiness Acquisition, Pro Forma Net Income (Loss) 3 monthBusiness Acquisition, Pro Forma Net Income (Loss) 6 monthBusiness Acquisition, Pro Forma Net Income (Loss) 9 monthBusiness Acquisition, Pro Forma Net Income (Loss) 12 monthBusiness Acquisition, Pro Forma Net Income (Loss) 12 month as first filed
2021-12-31-$13.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$14.87M
derived: sum of 2 quarters · filed 2023-03-31
-$32.56M
derived: sum of 3 quarters · filed 2023-03-31
-$45.12M
10-K · filed 2023-03-31
-$45.12M
10-K · filed 2022-10-21
2021-09-30-$991.13K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$18.68M
derived: sum of 2 quarters · filed 2022-11-14
-$31.23M
10-Q · filed 2022-11-14
2021-06-30-$17.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-21
-$30.24M
10-Q · filed 2022-10-21
2021-03-31-$12.55M
10-Q · filed 2022-10-21
2020-12-31-$34.61M
10-K · filed 2022-10-21